Cardiovascular Phenotypes of Kinin B 2 Receptor– and Tissue Kallikrein–Deficient Mice
- 1 July 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 40 (1) , 90-95
- https://doi.org/10.1161/01.hyp.0000021747.43346.95
Abstract
To clarify the role of the kallikrein-kinin system in cardiovascular homeostasis, the systemic and regional hemodynamics of kinin B2 receptor–deficient (B2−/−) and tissue kallikrein–deficient (TK−/−) mice were compared with their wild-type (WT) littermates on a pure C57BL/6 genetic background. B2−/−, TK−/−, and WT adult mice were normotensive and displayed normal hemodynamic (left ventricular [LV] pressure, cardiac output, total peripheral resistance, dP/dtmax) and echocardiographic (septum and LV posterior wall thickness, LV diameter, LV mass, and LV fractional shortening) parameters. However, heart rate was lower in B2−/− mice compared with TK−/− and WT mice. In addition, B2−/− mice, but not TK−/− mice, exhibited lower coronary and renal blood flows and greater corresponding vascular resistances than did WT mice, indicating a tonic physiological vasodilating effect of bradykinin in these vascular beds. However, maximal coronary vasodilatation capacity, estimated after dipyridamole infusion, was similar in the 3 groups of mice. B2−/− mice were significantly more sensitive than were TK−/− mice to the vasoconstrictor effects of angiotensin II and norepinephrine. Finally, renin mRNA levels were significantly greater in B2−/− mice and smaller in TK−/− mice compared with WT mice. Taken together, these results indicate that under basal conditions, the kinin B2 receptor is not an important determinant of blood pressure in mice but is involved in the control of regional vascular tone in the coronaries and the kidneys. The phenotypic differences observed between TK−/− and B2−/− mice could be underlain by tissue kallikrein kinin–independent effect and/or kinin B1 receptor activation.Keywords
This publication has 22 references indexed in Scilit:
- Centrally bradykinin B2-receptor-induced hypertensive and positive chronotropic effects are mediated via activation of the sympathetic nervous systemJournal Of Hypertension, 1999
- Intrarenal infusion of bradykinin elicits a pressor response in conscious rats via a B2-receptor mechanismCanadian Journal of Physiology and Pharmacology, 1999
- Noradrenaline release from rat sympathetic neurones triggered by activation of B2bradykinin receptorsBritish Journal of Pharmacology, 1997
- Bradykinin B2-receptor-mediated Stimulation of Exocytotic Noradrenaline Release from Cardiac Sympathetic NeuronsJournal of Molecular and Cellular Cardiology, 1997
- Kinins and Endothelial Control of Vascular Smooth MuscleAnnual Review of Pharmacology and Toxicology, 1995
- Kinin actions on renal papillary blood flow and sodium excretion.Hypertension, 1993
- The actions of bradykinin and lys-bradykinin on tracheal blood flow and smooth muscle in anaesthetized sheepPulmonary Pharmacology, 1991
- Genomic sequencing.Proceedings of the National Academy of Sciences, 1984
- Exaggerated sympathetic responses to bradykinin in spontaneously hypertensive rats.Hypertension, 1981
- Direct action of kallikrein and other proteases on the renin-angiotensin system.Hypertension, 1981